Anecortave Acetate Risk-Reduction Trial (AART)

Trial Profile

Anecortave Acetate Risk-Reduction Trial (AART)

Phase of Trial: Phase III

Latest Information Update: 29 May 2014

At a glance

  • Drugs Anecortave (Primary)
  • Indications Dry age-related macular degeneration
  • Focus Registrational; Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 29 May 2014 New trial record
    • 20 Apr 2012
    • 09 May 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top